RE: All time high28 May 2026 15:10
Absolutely it is possible, but we need some transformational news which the market likes. This has happened with many small life science companies, it’s certainly not without precedent. Note the very small volume of shares that are traded daily, and I think most of FAB is in really sticky hands. Therefore good news like an antibody in clinical testing, NCI agreement, another JV FAB could really rocket